Technology | August 30, 2013

Philips Unveils Intelligent Ultrasound System to Greatly Increase Speed of Exam Times

FDA-cleared system uses artificial intelligence to help improve reproducibility

Epiq ultrasound system, anatomical intelligence, echo
Epiq ultrasound system, anatomical intelligence

August 30, 2013 — Philips Healthcare launched the Epiq ultrasound system, a first-of-its-kind ultrasound architecture that offers a new approach to creating ultrasound images. Making its debut at the European Society of Cardiology (ESC) 2013 Congress in Amsterdam, Epiq features a new imaging technology called nSIGHT that, when combined with Philips' new Anatomical Intelligence technology, delivers faster speed and improved image clarity. It has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Anatomical Intelligence is a rich database of anatomic structural models and adaptive system technology that allows the ultrasound’s computer to automatically identify the anatomy being imaged without human interface. The Epiq system is the first to have this technology built into an ultrasound system. Philips said the system is capable of efficiently producing more definitive clinical results. Anatomical Intelligence provides advanced organ modeling, image slicing and proven quantification, making exams easier to perform, more reproducible and delivering new levels of clinical information. 

Epiq offers specific innovations for cardiology, radiology, OB/GYN and general imaging. These technologies include: 

  • xMatrix 3-D Tranesophageal echo (TEE) and the Anatomically Intelligent Mitral Valve Navigator, which provide a key live 3-D planning solution that allows physicians to make more informed decisions before and during heart valve procedures;
  • nSIGHT Imaging technology, a new imaging architecture that provides highly detailed ultrasound images and very good temporal resolution; and
  • Enhanced penetration at higher frequencies, which improves imaging, even on patients with high body mass index, where ultrasound has previously been inconclusive.


"Philips is at the forefront of imaging technology innovation, and with Epiq, we are pioneering a way to address significant imaging issues faced by medical professionals in the clinical setting," said Gene Saragnese, CEO Healthcare Imaging Systems, Philips Healthcare. "The combination of Anatomical Intelligence and the use of nSIGHT Imaging technology is a major milestone in the history of ultrasound technology."

"The image quality of Epiq is truly impressive," said Roberto Lang, M.D., director of cardiac imaging and professor of medicine, University of Chicago. "I also appreciate the numerous design elements that make Epiq easier to operate including the standby battery, easy-to-connect transducers and portability; it is clear that Epiq is a system built for today's healthcare environment."

The Epiq ultrasound system also includes other new features. It uses a new ergonomic design, and its weight, 230 pounds, makes it lightweight and more maneuverable than most premium, cart-based ultrasound systems. A noise test determined that Epiq runs at 37-41 dB, which is equivalent to the sound in a library. A new tablet-like interface results in dramatic reduction in reach and button pushes, with 40-80 percent less reach and 15 percent fewer steps. 

Philips said the system offers improved image quality with up to a 76 percent increase in penetration and up to 213 percent increase in temporal resolution.  The vendor also said its SmartExam technology increases automation and reproducibility of results, which decreases exam time by 30-50 percent, keystrokes by as many as 300 per exam, and results in a higher level of consistency among users. An example of this is auto Doppler, which takes time-consuming color box positioning and sample volume placement from 10 steps to three steps, and reduces the number of repetitive button pushes by an average of 67.9 percent.

For more information: www.philips.com

Related Content

The key trends Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Imagesbserved at 2020 Radiological Society of North America (RSNA) meeting all focused around COVID-19 (SARS-CoV-2) and the impact it has had on radiology. #RSNA #RSNA20 #RSNA2020

Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Images

Feature | RSNA | January 20, 2021 | By Melinda Taschetta-Millane and Dave Fornell
MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI.

MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI. Image courtesy of Exact Imaging

Feature | Prostate Cancer | January 20, 2021 | By Brian Wodlinger, Ph.D.
Historically when a patient had an elevated PSA (prostate specific antigen) test their urologist would take the next
Vendor neutral archives enable a single, central location to store large volumes of radiology data, but now need to be able to house data from dozens of other departments with a wide array of data formats. This article originally ran as an introduction to the Vendor Neutral Archives comparison chart.
Feature | Vendor Neutral Archive (VNA) | January 20, 2021 | By Dave Fornell
Most radiologists and clinicians are not trained as...
Previously approved by FDA in the USA, MyLab X8 expands the reach of the MyLab Ultrasound Product Line with a fully featured premium imaging solution, integrating the latest technologies and delivering superior image quality without compromising workflow or efficiency.
News | Ultrasound Imaging | January 20, 2021
January 20, 2021 — Esaote North America announces that the...
AI Metrics, LLC, a medical imaging startup focused on augmented intelligence to improve patient care, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s flagship image analysis platform.
News | Artificial Intelligence | January 18, 2021
January 18, 2021 — AI Metrics, LLC, a medical imaging startup focused on augmented intelligence to improve patient ca
The U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency's oversight of AI/ML-based medical software.
News | Artificial Intelligence | January 12, 2021
January 12, 2021 — The U.S.
Myocarditis among recovering COVID-19 athletes less common than previously reported

Getty Images

News | Cardiac Imaging | January 11, 2021
January 11, 2021 — In a letter published in the December issue of the American Heart Association's...
Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound.

Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound. Image courtesy of UVA Health

News | Focused Ultrasound Therapy | January 08, 2021
January 8, 2021 — A scalpel-free alternative to brain surgery has the potential to benefit people with...
Ultromics will offer its artificial intelligence driven EchoGo Pro as a stress-echo module in the EchoGo suite alongside EchoGo Core, its AI solution for automated systolic function and strain analysis. The EchoGo suite is a cloud-based service that uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site. #AI #AIhealthcare #AIecho

Ultromics will offer its artificial intelligence driven EchoGo Pro as a stress-echo module in the EchoGo suite alongside EchoGo Core, its AI solution for automated systolic function and strain analysis. The EchoGo suite is a cloud-based service that uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

News | Artificial Intelligence | January 06, 2021
January 6, 2021 — The U.S.